Skip to content
Delayed ~15 min

BSX Boston Scientific

Health Care · S&P 500

Next earnings: not announced yet

What 32 analyst firms say about Boston Scientific: their latest ratings, price targets and how far the stock is from them. How it works

42.75 USD−1.89 (−4.23%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+26.6%to the avg target 54.11 USD+11.36 USD
Buy 18 · Hold 10 · Sell 1

29 rated views · 33 analyst/firm records · 32 firms

Latest report30 Oct 2026avg report date 22 Sep
Target rangePrice is below every target

Radar score

  • S&P 500 · Top Picks · 6MBelow the Radar threshold of 8051
  • S&P 500 · Safest consensus · 6MBelow the Radar threshold of 8042

Recent analyst activity · last 90 days

Our tracked history has 39 reports on BSX from 23 analyst firms in the last 90 days (33 firms in the past year).

Comparing each firm's latest target with its previous one: 19 lowered it and 2 left it unchanged.

Ratings, latest available report against the previous one: 0 upgrades and 3 downgrades.

Latest observed target change: Barclays lowered its target from $89.00 (set 28 May 2026) to $45.00 on 30 Oct 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
ArgusDavid ToungHold31 Jul 2026—
BairdDavid RescottBuy29 Oct 202651.00 USD
Bank of America SecuritiesBob Hopkins—12 Jun 202661.00 USD
BarclaysChristopher PasqualeHold30 Oct 202645.00 USD
BernsteinLee HambrightBuy29 Oct 202649.00 USD
BTIGMarie ThibaultBuy29 Oct 202649.00 USD
Canaccord GenuityWilliam PlovanicBuy29 Oct 202648.00 USD
CitigroupJoanne WuenschHold29 Oct 202644.00 USD
DaiwaNarumi NakagiriHold30 Jul 202644.00 USD
DBSNico ChenBuy1 Jul 2026—
Deutsche BankPito ChickeringBuy29 Oct 202648.00 USD
Evercore ISIVijay KumarBuy29 Jul 202652.00 USD
Goldman SachsDavid RomanBuy14 Jul 202657.00 USD
JefferiesMatthew TaylorHold28 Oct 202646.00 USD
JPMorganUnnamed analystHold28 Oct 202646.00 USD
Leerink PartnersMike KratkyBuy29 Oct 202650.00 USD
MizuhoAnthony PetroneConflictConflicting reports · excluded29 Oct 202650.00 USD
National Bank FinancialUnnamed analyst—2 Feb 2026115.00 USD
NeedhamMike MatsonBuy28 Oct 202648.00 USD
OppenheimerSuraj KaliaHold29 Oct 202665.00 USD · 21 Sep 2026
Piper SandlerMatthew O'BrienBuy10 Sep 202660.00 USD
Raymond JamesJayson T BedfordBuy29 Oct 202657.00 USD · 30 Jul 2026
RBC Capital MarketsKendall AuBuy29 Oct 202652.00 USD
RBC Capital MarketsShagun SinghBuy30 Jul 202670.00 USD
RedburnEd Ridley-DayBuy30 Jul 2026Conflicting reports · excluded
StifelRick WiseBuy26 Oct 202655.00 USD
TD CowenJoshua JenningsHold30 Oct 202646.00 USD
TruistRichard NewitterBuy14 Oct 202651.00 USD
UBSPatrick WoodBuy29 Oct 202657.00 USD
Weiss RatingsUnnamed analyst—2 Oct 2026—
Wells FargoLarry BiegelsenHold29 Oct 202645.00 USD
Wolfe ResearchMike PolarkHold29 May 2026—
Data feed RESEARCHResearch TeamSell5 Jun 2026Conflicting reports · excluded

Partial coverage · checked 6 Nov (6 Nov 2026, 02:20 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.